Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million
Globe Newswire23-01-2023, 20:06
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68% 11-01-2024, 19:00